Description
LIVAGEN 20mg contains Livagen, a synthetic short-chain peptide composed of four amino acids in the sequence Lys-Glu-Asp-Ala (KEDA). Its defined tetrapeptide structure makes it a useful reference compound for laboratory studies involving short-peptide chemistry, molecular interactions, and related biological research.
Livagen belongs to a group of short synthetic peptides that have been investigated in experimental and preclinical research. Published studies involving KEDA have examined its behavior in cellular and molecular systems; however, the available evidence remains limited and does not establish therapeutic safety or effectiveness in humans.
Each vial contains 20mg of LIVAGEN and is supplied for controlled laboratory and analytical research applications.
Product Details
- Compound: Livagen
- Amount: 20mg
- Sequence: Lys-Glu-Asp-Ala
- Short sequence: KEDA
- Classification: Synthetic tetrapeptide
- Molecular formula: C18H31N5O9
- Molecular weight: Approximately 461.46 Da
- Form: Research peptide vial
- Intended use: Laboratory and analytical research
Reviews
There are no reviews yet.